Covetrus, Inc.
CVET · NASDAQ
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $2,905 | $2,317 | $2,756 | $2,485 |
| - Cash | $87 | $117 | $183 | $187 |
| + Debt | $1,049 | $1,047 | $1,046 | $1,073 |
| Enterprise Value | $3,867 | $3,247 | $3,619 | $3,371 |
| Revenue | $1,217 | $1,148 | $1,122 | $1,162 |
| % Growth | 6% | 2.3% | -3.4% | – |
| Gross Profit | $229 | $225 | $212 | $216 |
| % Margin | 18.8% | 19.6% | 18.9% | 18.6% |
| EBITDA | $52 | $58 | $50 | $43 |
| % Margin | 4.3% | 5.1% | 4.5% | 3.7% |
| Net Income | -$4 | -$2 | -$3 | -$4 |
| % Margin | -0.3% | -0.2% | -0.3% | -0.3% |
| EPS Diluted | -0.029 | -0.015 | -0.022 | -0.029 |
| % Growth | -97.2% | 33.2% | 25.7% | – |
| Operating Cash Flow | -$6 | -$33 | $44 | $59 |
| Capital Expenditures | -$15 | -$11 | -$22 | -$14 |
| Free Cash Flow | -$21 | -$44 | $22 | $45 |